Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

WELL Health Technologies Corp T.WELL

Alternate Symbol(s):  WHTCF | T.WELL.DB

WELL Health Technologies Corp. is a Canada-based practitioner-focused digital healthcare company. Its healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. Its business units include Canadian Patient Services, WELL Health USA Patient and Provider Services, and SaaS and Technology Services. Its solutions enable more than 38,000 healthcare providers between the United States and Canada and power owned and operated healthcare ecosystem in Canada with over 200 clinics supporting primary care, specialized care, and diagnostic services. In the United States its solutions are focused on specialized markets such as the gastrointestinal market, women's health, primary care, and mental health. WELL Health USA Patient and Provider Services consists of four assets: CRH Medical, Provider Staffing, Circle Medical and Wisp. It provides cybersecurity protection and patient data privacy solutions.


TSX:WELL - Post by User

Post by monty613on Jan 24, 2022 1:43pm
158 Views
Post# 34354017

reconciliation of Net Loss to EBITDA (Q3)

reconciliation of Net Loss to EBITDA (Q3)here is the breakdown from Q3. decide for yourself which one-time expenses and non-cash expenses are warranted to be added back for the purposes of calculating recurring cashflow.


Net Loss (10,408)
Dep/Amort 16,326
Income Taxes 2,854
Interest Income (71)
Interest Expense 3,214
Rent Expense on Finance Leases (1,909)
Stock Based Compensation 9,447
FX Gain (387)
Time Based Earn Out Expenses 1,393
Share of Loss of Associates 97
Transaction Costs Expensed 1,809

Adj EBITDA 22,275
<< Previous
Bullboard Posts
Next >>